Siqing Fu, M.D., Ph.D. MD Anderson Cancer Center discusses Soricimed Announces Resumption of MD Anderson’s Investigator-Initiated Phase 1b Clinical Trial of SOR-C13
Â
Soricimed Announces Resumption of MD Anderson’s Investigator-Initiated Phase 1b Clinical Trial of SOR-C13 – Siqing Fu, M.D., Ph.D. MD Anderson Cancer Center @MDAndersonNews #pancreaticc…
By Editor